Español
Portugués

Programa

JUNE - MONDAY 10th 

17:00 - 19:30     Business Meeting & PAOS: Business Meeting Meeting with the patient representatives
                               RiboEurope EJPRD consortium & PAOs
                               Visit to Biomedical Innovation Unit labs and CliniStem Manufacturing facility (If someone                                   is interested)

20:30 - 22:30     Dinner with the patient representatives and the invited speakers

                               (Hotel Índigo Madrid Princesa)

 

JUNE - TUESDAY 11th 

 

08:30 - 08:45     REGISTRATION

08:45 - 08:55     Welcome and Introduction

                           Marije Bartels / Pierre-Emmanuel Gleizes / Susana Navarro

08:55 - 10:15     Basic & translational reseach I (Ribosome biology):
                          (Chairs: Denis Lafontaine & Marie-Françoise O’Donohue)

08:55 - 09:10     Introduction:
                           Probing the ribosomal RNA methylation repertoire in Diamond-Blackfan anemia

                           Denis Lafontaine

09:10 - 09:30     Ribosomes as drivers and targets in colorectal cancer
                          John Knight

09:30 - 09:45     Investigating the function of HEATR3 in ribosome biogenesis and the                                                         nucleolar surveillance pathway
                           Amee J. George

09:45 - 10:00     SURF2 is a new player in nucleolar stress response
                           Simon Lebaron
 

10:00 - 10:15     Detecting pre-rRNA processing defects by RNA capture and capillary electrophoresis
                           for DBA study and diagnosis

                           Pierre-Emmanuel Gleizes

 

10:15 - 12:00     Basic & translational reseach II (Hematopoiesis):
                          (Chairs: Lydie Da Costa, Emile van den Akker)

10:15 - 10:30     Deciphering disease mechanisms in DBA, one cell at a time
                           Deena Iskander

10:30 - 10:45     Diamond Blackfan Anemia: Impact of the arginine-polyamine-hypusine axis on
                           erythroidprogenitor metabolism and differentiation

                           Sandrina Kinet
10:45 - 11:00     Transfusion-ready red blood cell generation from induced pluripotent stem cells
                           Emile van den Akker

11:00 - 11:30 Morning Coffee break

11:30 - 11:45     Investigating Novel Erythropoietic Factors in Diamond-Blackfan Anemia Syndrome
                          via Erythroblast Differentiation Assays

                          Devon Germain
11:45 - 12:00    Response to anaemic stress in Diamond-Blackfan anaemia reveals metabolic
                          decompensation

                          Helen Brown
 

12:00 - 13:15    Mechanisms of treatment independence/hematopoietic evolution
                          (Chairs: Allan Warren, Denna Iskander)
12:00 - 12:15    Mechanisms of somatic genetic rescue in germline ribosomopathy
                          Alan Warren
12:15 - 12:30     Natural gene therapy in DBA syndrome explored using single cell genomics
                           Marcin Wlodarski
12:30 - 12:45     Treatment-independence due to self-reverting mutation in DBA patients
                           Paola Quarello
12:45 - 13:15     PANNEL DISCUSSION: somatic mosaicis and clonal slection in DBA
                           Alan Warren, Marcin Wlodarski, Paola Quarello

13:15 - 14:30 LUNCH and poster viewing

14:30 - 16:15     Novel & Advanced therapies
                          (Chairs: Charlotte Niemeyer, Paula Río )
14:30 - 15:00     “KEYNOTE LECTURE: Advances in Hematopoietic Stem Cell Gene Therapy”
                           Juan Bueren
15:00 - 15:15     Development of gene therapy for RPS19 deficient Diamond Blackfan anemia
                           Stepahn Karlsson
15:15 - 15:30     Development of a gene editing approach for the treatment of RPL5-deficient Diamond-                            Blackfan anemia patients
                          Manuel Palacios
15:30 - 15:45    Preclinical development of RPS19 lentiviral vector for gene therapy (ON LINE                                            PRESENTATION)
                          Senthil Bhoopalan

15:45 - 16:00     Single-cell-multiomics of gene therapy treated ribosomal protein S19-deficient                                           Diamond-Blackfan Anemia patient cells demonstrates molecular efficacy and                                           uncover new pathogenic mechanisms
                           Johan Flygare
16:00 - 16:15     Exploring Tyrosine Kinase Inhibitors as Potential Therapeutics for Diamond-Blackfan
                           Anemia

                           Victoriano Mulero

16:15 - 16:45 Coffe break

16:45 - 17:15      PANNEL DISCUSSION & PATIENT PERSPECTIVE

                 Stefan Karlsson, Apriligen, Johan Flygare

                 Marcin Wlodarski, Senthil Bopahalan (on line)

                            Susana Navarro, Juan Bueren

                            Bas Reijnen

17:15 - 17:50     Posters session I
                           (Chairs: Susana Navarro & Marien Van der Stel)
                           SHORT TALKS: selected posters session
 

17:15 - 17:30     Elucidating the Role of RPL5/uL18 Mutations in the Pathogenesis of Diamond-                                           Blackfan Anemia
                           Federica Marchesini
17:30 - 17:35     iPSC disease models to study and treat Diamond-Blackfan Anemia Syndrome (DBAS)
                       
   Chantal Clark
17:35 - 17:40     Towards an improved erythroid production from iPSCs
                           Marien Van der Stel
17:40 - 17:45     Elucidating glucocorticoid-responsiveness in Diamond-Blackfan anemia syndrome
                           using iPSC-derived erythroblasts

                           Teun Slijkerman
17:45 - 17:50     The biology of RPS19-R62W: Interacting proteins and their roles in red blood cell
                           differentiation

                           Stefan Weitzer

19:30 TOURISTIC TOUR & TAPAS DINNER "EL RINCÓN DE LA CAVA"
              Meeting point Plaza España at 19:30

 

JUNE - WEDNESDAY 12th

 

09:00 - 10:30     Allogeneic Hematopoietic Stem Cell Transplantation
                           (Chairs: Cristina Beléndez, Marije Bartels)
09:00 - 09:30     KEYNOTE LECTURE: From Transfusion to Stem Cell Transplantation
                          Charlotte Niemeyer
09:30 - 09:45     An interesting/difficult HSCT case
                           Marije Bartels
09:45 - 10:00     EBMT overview in bone failures and DBA
                           Carlo Dufour
10:00 - 10:30     PANNEL DISCUSSION:
                           Elective HSCT in DBA patients: Is reduced conditioning an option?
                           Brigitte Strahm / Carlo Dufour / Jeffrey Lipton / Cristina Belendez / Marco Zecca

10:30 - 11:00 Coffee break
 

11:00 - 12:30     The adult patient with DBA syndrome
                          (Chairs: Brigitte Strahm & Hannah Tamary)
11:00 - 11:30     KEYNOTE LECTURE: Hematological and systemic features of DBA in adults in                                           Germany
                           Alexander Puzik
11:30 - 11:45     Pregnancy and genetic counseling
Lydie Da Costa
11:45 - 12:00     Women’s Health in Diamond Blackfan Anemia Syndrome: Data from the Diamond
                          Blackfan Anemia Registry

                           Adriana Vlachos
12:00 - 12:15     How do I transition DBA patients?
                           Cristina Belendez

12:15 - 12:30      The Global Diamond Blackfan Anemia Cancer Consortium
                            Jeffrey Lipton

12:30 - 14:00 LUNCH + poster viewing
 

14:00 - 14:50     The patient perspective
                           (Chairs: Bas Reijnen & Colin Noel )
14:00 - 14:20     Beate Buchholz & Boris Marte

14:20 - 14:50     PANNEL DISCUSSION: What needs to be done to improve the health status of adults                               with DBA?
                           (Chair: Alex Puzik)
                           Beate Buchholz / Boris Marte / Carlos Carrión / Alexander Puzik / Adriana Vlachos / Dagmar                             Pospisilova
 

14:50 - 15:05     Late breaking presentation session
                           (Chairs:Irma Diazani & Eva-Maria Kornemann)
Clonal hematopoiesis in long-term survivors of pediatric hematopoietic stem cell transplantation
                           Mirjam Belderbos

15:05 - 15:30     Poster Session II and Award
                           (Chairs:Irma Diazani & Eva-Maria Kornemann)
15:05 - 15:10     De novo heterozygous RPL8 missense variant in a patient from Yakutia with Diamond-
                           Blackfan anemia

                           Anna V Pavlova
15:10 - 15:15     Learning through registries, a desired and demanded need by patient associations,
                           clinicians and investigators. Preliminary data from the Spanish Registry of                                                 Blackfan Diamond Anemia Syndrome (DBA).

                           Alba González-Guerrero
15:15 - 15:20     Implementing Human Phenotype Ontology into the German DBA registry what’s the                                 benefit?
                           Eva-Maria Kornemann
15:20 - 15:30     Poster award
                           (Chairs: Marije Bartels, Susana Navarro, Pierre-Emmanuel Gleizes)
 

15:30 - 16:00 Coffee break
 

16:00 - 17:00     How can we implement DBA Guidelines efficiently?
                           (Chairs: Paola Quarello & Marcel Hibert)
16:00 - 16:20     1. Stepwise approach from diagnosis to treatment: Overcoming practical challenges
                           Thierry Leblanc
16:20 - 16:40     2. Online implementation and future updates
                           Marcin Wlodarski
16:40 - 17:00     PANNEL DISCUSSION
                           Thierry Leblanc & Marcin Wlodarski
• Are there different laboratory reference ranges available between a healthy and a DBA
patient (e.g. for vitamin d)?
• Recommendations for food supplements or diets (e.g. vitamin d, leucine,..)
• Any new evidence for the influence of epo on hb in dba patients available?
• Dba patients who are not transfusion-dependent: influence of exjade on hematopoiesis (is
hb (temporarily) lower than without exjade?), ferritin and organ iron overload in comparison
to transfusion-dependent patients
• Describing the phenotype(s) of dba patients: is it possible to classify/describe different
phenotypes and to adapt treatment recommendations for each phenotype?
• Covid: is evidence about the course/duration of a covid disease in dba patients available?
Vaccination recommendation?
 

17:00 - 17:15 Closing remarks
                             Marije Bartels / Pierre-Emmanuel Gleizes / Susana Navarro

 

 

CIEMAT Building 1: Main Ballroom